No Data
No Data
Ionis Pharmaceuticals Announces CHMP Recommends Approval for Wainzua
Express News | Ionis And AstraZeneca's WAINZUA Recommended For EU Approval As First Self-Administered Treatment For HATTR-PN
Express News | Wainzua (Eplontersen) Recommended for Approval in the EU by Chmp for the Treatment of Adults With Polyneuropathy Associated With Hereditary Transthyretin-Mediated Amyloidosis
Morgan Stanley Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Cuts Target Price to $55
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Ionis Pharmaceuticals (IONS) and Amicus (FOLD)
Wolfe's Tax Loss Selling Stocks Within Communications, Discretionary, Staples, Energy, Financials, Health Care